Literature DB >> 16483550

The neuropsychological profile of psychotic major depression and its relation to cortisol.

Rowena G Gomez1, Shelley H Fleming, Jennifer Keller, Benjamin Flores, Heather Kenna, Charles DeBattista, Brent Solvason, Alan F Schatzberg.   

Abstract

BACKGROUND: Our study described the neuropsychological profile of psychotic major depression (PMD) compared to nonpsychotic major depression (NPMD) patients and psychiatrically healthy controls (HC). We predicted that higher cortisol levels would be associated with greater cognitive deficits.
METHODS: Twenty-nine PMDs, 24 NPMDs, and 26 HCs were recruited at Stanford University Medical Center. Psychiatric ratings, cortisol levels from 1800-0900 hours, and neuropsychological test data were obtained.
RESULTS: PMDs had more severe cognitive impairments compared with NPMDs and HCs with the exception of simple verbal attention. PMDs had elevated mean cortisol levels from 1800 to 0100 hours which were significantly correlated with poorer verbal memory and psychomotor speed performance. Cortisol slopes from 1800 to 0100 hours were also significantly correlated with verbal memory and working memory.
CONCLUSIONS: While PMDs' ability to attend passively to information appears intact, they have more difficulty processing, manipulating, and encoding new information. Elevated cortisol levels, as seen in PMD patients, are associated with poorer cognitive performance especially related to verbal memory for lists of words and working memory.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16483550     DOI: 10.1016/j.biopsych.2005.11.010

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  39 in total

1.  Cognitive impairments in major depression and bipolar disorders.

Authors:  Philip D Harvey
Journal:  Psychiatry (Edgmont)       Date:  2007-01

2.  Abnormal cortisol awakening response predicts worse cognitive function in patients with first-episode psychosis.

Authors:  M Aas; P Dazzan; V Mondelli; T Toulopoulou; A Reichenberg; M Di Forti; H L Fisher; R Handley; N Hepgul; T Marques; A Miorelli; H Taylor; M Russo; B Wiffen; A Papadopoulos; K J Aitchison; C Morgan; R M Murray; C M Pariante
Journal:  Psychol Med       Date:  2010-06-09       Impact factor: 7.723

3.  The mineralocorticoid receptor agonist, fludrocortisone, differentially inhibits pituitary-adrenal activity in humans with psychotic major depression.

Authors:  Anna Lembke; Rowena Gomez; Lakshika Tenakoon; Jennifer Keller; Gregory Cohen; Gordon H Williams; Fredric B Kraemer; Alan F Schatzberg
Journal:  Psychoneuroendocrinology       Date:  2012-06-21       Impact factor: 4.905

Review 4.  Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: a meta-analysis and review.

Authors:  Hannah R Snyder
Journal:  Psychol Bull       Date:  2012-05-28       Impact factor: 17.737

Review 5.  Chronic stress-induced hippocampal vulnerability: the glucocorticoid vulnerability hypothesis.

Authors:  Cheryl D Conrad
Journal:  Rev Neurosci       Date:  2008       Impact factor: 4.353

Review 6.  Chronic stress- and sex-specific neuromorphological and functional changes in limbic structures.

Authors:  Katie J McLaughlin; Sarah E Baran; Cheryl D Conrad
Journal:  Mol Neurobiol       Date:  2009-07-31       Impact factor: 5.590

7.  Hippocampal and amygdalar volumes in psychotic and nonpsychotic unipolar depression.

Authors:  Jennifer Keller; Lin Shen; Rowena G Gomez; Amy Garrett; H Brent Solvason; Allan Reiss; Alan F Schatzberg
Journal:  Am J Psychiatry       Date:  2008-05-01       Impact factor: 18.112

8.  Cognitive impairment in affective psychoses: a meta-analysis.

Authors:  Emre Bora; Murat Yücel; Christos Pantelis
Journal:  Schizophr Bull       Date:  2009-09-18       Impact factor: 9.306

9.  Insular cortex abnormalities in psychotic major depression: relationship to gender and psychotic symptoms.

Authors:  Jeremy D Cohen; Taylor Nichols; Jennifer Keller; Rowena G Gomez; Alan F Schatzberg; Allan L Reiss
Journal:  Neurosci Res       Date:  2013-03-05       Impact factor: 3.304

10.  Mineralocorticoid receptor stimulation improves cognitive function and decreases cortisol secretion in depressed patients and healthy individuals.

Authors:  Christian Otte; Katja Wingenfeld; Linn K Kuehl; Michael Kaczmarczyk; Steffen Richter; Arnim Quante; Francesca Regen; Malek Bajbouj; Frank Zimmermann-Viehoff; Klaus Wiedemann; Kim Hinkelmann
Journal:  Neuropsychopharmacology       Date:  2014-07-18       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.